Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New liver safety information for Strattera

Dec. 22, 2004

Accera establishes advisory boards to guide development efforts

Dec. 22, 2004

AV-201 enters phase I/II trial for Parkinson's disease

Dec. 22, 2004

Lundbeck files for E.U. approval of Cipralex for generalized anxiety disorder

Dec. 21, 2004

Therapeutic benefits reported for modafinil in cocaine dependence and MDD

Dec. 21, 2004

Potential neuroprotective effects for rifampicin in Parkinson's disease

Dec. 21, 2004

Avanir commences NDA submission for Neurodex

Dec. 21, 2004

Eisai receives positive opinion for Zonegran in Europe

Dec. 20, 2004

Long-term safety of bicifadine evaluated in new phase III trial

Dec. 20, 2004

New analgesic agents prepared and tested at LSU

Dec. 20, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...